Zhongqi Capital
Overview
Zhongqi Capital is a Chinese private equity firm investing in growth-stage companies across multiple sectors. The firm focuses on sectors such as biotechnology, healthcare, medical, advanced materials, oil and gas, sensor, industrial manufacturing, and laser technologies. Zhongqi Capital has a track record of leading investments in early-stage ventures, with an average round size of $3 million, and has been active in the Chinese market since at least 2023.
Investment Focus
- Growth-stage companies in China
Portfolio Companies
Get the full list of 54,000+ investors
Zhongqi Capital and every other firm and angel in the database — as one spreadsheet you keep.
$19one-time payment · no subscription- All 54,000+ investors — VC firms, private equity, family offices and angels
- The key person to contact at each one, with their job title
- Their work email address
- Their phone number
- Their LinkedIn profile
- Delivered as a single .xlsx file — download it as many times as you like
Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.
Frequently asked questions about Zhongqi Capital
What sectors does Zhongqi Capital invest in?
Zhongqi Capital invests in Healthcare, Industrial Manufacturing, Biotechnology, Oil and Gas, Medical and Advanced Materials, and is based in China. Zhongqi Capital is listed as a private equity in the ConnectSafely investor database.
What stage does Zhongqi Capital invest at?
Zhongqi Capital backs companies at Early Stage, Growth, Late Stage, Pre-IPO and Buyout, writing cheques of 3M - 3M.
Which regions does Zhongqi Capital invest in?
Zhongqi Capital invests across China.
What companies has Zhongqi Capital invested in?
Zhongqi Capital's portfolio includes Rona Therapeutics, Deptrum, Guiyan Electronic, Delova Biotech, Sinoma High-tech Materials, Bioyi, Fudou New Materials and Lance Technology.
Last updated · Source: ConnectSafely investor database
